Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “18-FDG”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Not applicableActive Not RecruitingNCT00194298
What this trial is testing

FDG-PET Imaging in Complicated Diabetic Foot

Who this might be right for
Diabetic Foot Disease
University of Pennsylvania 240
Not applicableStudy completedNCT01269970
What this trial is testing

Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy

Who this might be right for
Esophageal Carcinoma (Squamous Cell Carcinoma - Adenocarcinoma)
Universitaire Ziekenhuizen KU Leuven
Not applicableStudy completedNCT03419221
What this trial is testing

Impact of 18 FDG PET/CT on the Management of Patients With Staphylococcus Aureus Bloodstream Infection

Who this might be right for
Staphylococcus Aureus
University Hospital, Montpellier 291
Testing effectiveness (Phase 2)Ended earlyNCT02736448
What this trial is testing

177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positive, Gastro-entero-pancreatic Neuroendocrine Tumors

Who this might be right for
Gastro-entero-pancreatic Neuroendocrine Tumors
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 35
Not applicableLooking for participantsNCT05748990
What this trial is testing

Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia

Who this might be right for
SchizophreniaHealthy
Centre for Addiction and Mental Health 20
Not applicableUnknownNCT00688337
What this trial is testing

Correlation Between Fluorodeoxyglucose (FDG) and FLT Uptake and Gene-Expression Oncotype Assay in Patients With Breast Cancer

Who this might be right for
Breast Cancer
Tel-Aviv Sourasky Medical Center 100
Not applicableUnknownNCT06558357
What this trial is testing

Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia Rheumatica

Who this might be right for
Inflammatory Rheumatism18-FDGPositron-emission Tomography
University Hospital, Brest 210
Not applicableWithdrawnNCT01314677
What this trial is testing

Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation

Who this might be right for
Stage IIIA Non-small Cell Lung Cancer
City of Hope Medical Center
Not applicableUnknownNCT00385164
What this trial is testing

The Utility of FDG-PET for Radiation Treatment in NSCLC

Who this might be right for
Lung NeoplasmsPositron Emission Tomography
AHS Cancer Control Alberta 50
Not applicableUnknownNCT03679936
What this trial is testing

Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions and Differentiating Multiple Primary Lung Cancer From Intrapulmonary Metastases of Non-small Cell Lung Cancer

Who this might be right for
Positron-Emission TomographyNon-small Cell Lung Cancer
Fifth Affiliated Hospital, Sun Yat-Sen University 120
Not applicableUnknownNCT00364663
What this trial is testing

The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT03665155
What this trial is testing

First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 11
Not applicableStudy completedNCT04920435
What this trial is testing

Prediction of the Response to Neoadjuvant Radiation Chemotherapy Through Texture Analysis Derived From Medical Imaging

Who this might be right for
Rectal Cancer
University Hospital, Brest 124
Not applicableStudy completedNCT02964442
What this trial is testing

Brown Adipose Tissue Activation and Energy Expenditure by Capsinoids Stimulation With Trimodality Imaging Using 18-FDG-PET, Fat Fraction MRI and Infrared Thermography

Who this might be right for
Brown Adipose Tissue
Singapore Institute of Food and Biotechnology Innovation 30
Not applicableStudy completedNCT06171464
What this trial is testing

Prognostic Value of Pre-therapy 18F-FDG PET/CT for the Outcome of 18 FDG PET-guided SIB-IMRT in Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
IRCCS San Raffaele 19
Testing effectiveness (Phase 2)Study completedNCT01237054
What this trial is testing

Imaging in MGUS, SMM and MM

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
National Cancer Institute (NCI) 31
Not applicableStudy completedNCT00754117
What this trial is testing

Early Response Assessment in Diffuse Large B-Cell Lymphoma (DLCL) Patients by 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET)

Who this might be right for
Diffuse Large B-cell Lymphoma
Weill Medical College of Cornell University 8
Very early researchStudy completedNCT00816335
What this trial is testing

Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Ohio State University Comprehensive Cancer Center 65
Not applicableStudy completedNCT00550628
What this trial is testing

Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer

Who this might be right for
Colorectal CancerNeoplasm of Uncertain Malignant Potential
Memorial Sloan Kettering Cancer Center 8
Not applicableStudy completedNCT03832348
What this trial is testing

Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment

Who this might be right for
Non Small Cell Lung Cancer
Centre Henri Becquerel 40
Next Page